Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer

BACKGROUND: This study was conducted to evaluate the efficacy and safety of paclitaxel-carboplatin combined with intercalated gefitinib in patients with advanced, untreated, nonsquamous non-small cell lung cancer. METHODS: A total of 29 patients were enrolled in the study. All patients were Chinese,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Autores principales: Yang, Jianliang, Shi, Yuankai, Zhang, Xiangru, Xu, Jianping, Wang, Bin, Hao, Xuezhi, Li, Junling, Yan, Wang
Formato: Artigo
Lenguaje:Inglês
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704326/
https://ncbi.nlm.nih.gov/pubmed/26766992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12074
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares